Chennai Meenakshi Multispeciality Hospital Reports Q3 FY26 Financial Results with Reduced Losses
Chennai Meenakshi Multispeciality Hospital Limited reported Q3 FY26 results showing reduced net losses of ₹54.06 lakhs compared to ₹62.95 lakhs in the previous year quarter. Total income grew to ₹937.96 lakhs from ₹909.31 lakhs year-over-year. For nine months, the company achieved ₹2810.70 lakhs in total income while narrowing losses to ₹108.75 lakhs from ₹168.66 lakhs previously.

*this image is generated using AI for illustrative purposes only.
Chennai Meenakshi Multispeciality Hospital Limited has released its unaudited financial results for the quarter and nine months ended December 31, 2025, showing mixed performance with reduced quarterly losses but continued operational challenges.
Financial Performance Overview
The hospital reported improved quarterly performance despite continuing losses. Total income from operations for Q3 FY26 reached ₹937.96 lakhs, representing growth from ₹909.31 lakhs in the corresponding quarter of the previous year.
| Metric | Q3 FY26 | Q3 FY25 | Change |
|---|---|---|---|
| Total Income from Operations | ₹937.96 lakhs | ₹909.31 lakhs | +3.15% |
| Net Loss After Tax | ₹54.06 lakhs | ₹62.95 lakhs | Reduced by 14.13% |
| Total Comprehensive Loss | ₹58.71 lakhs | ₹63.49 lakhs | Reduced by 7.53% |
Nine-Month Performance Analysis
For the nine-month period ended December 31, 2025, the company demonstrated revenue growth alongside improved loss management. Total income from operations increased to ₹2810.70 lakhs from ₹2608.10 lakhs in the previous year.
| Parameter | Nine Months FY26 | Nine Months FY25 | Variance |
|---|---|---|---|
| Total Income | ₹2810.70 lakhs | ₹2608.10 lakhs | +7.77% |
| Net Loss After Tax | ₹108.75 lakhs | ₹168.66 lakhs | Reduced by 35.52% |
| Loss Before Tax | ₹118.08 lakhs | ₹174.64 lakhs | Reduced by 32.39% |
Earnings Per Share and Capital Structure
The company's earnings per share reflected the operational losses across all reported periods. Basic and diluted EPS for Q3 FY26 stood at ₹-0.72 per share, compared to ₹-0.84 per share in Q3 FY25.
| EPS Details | Q3 FY26 | Q3 FY25 | Nine Months FY26 |
|---|---|---|---|
| Basic EPS | ₹-0.72 | ₹-0.84 | ₹-1.46 |
| Diluted EPS | ₹-0.72 | ₹-0.84 | ₹-1.46 |
| Equity Share Capital | ₹746.89 lakhs | ₹746.89 lakhs | ₹746.89 lakhs |
Corporate Governance and Compliance
The financial results were reviewed and recommended by the Audit Committee before receiving approval from the Board of Directors at their meeting held on February 11, 2026. The company has maintained compliance with SEBI regulations by filing detailed financial results with stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The complete format of the quarterly and nine-month financial results is available on the BSE website and the company's official website for stakeholder reference. The hospital continues to operate under the leadership of Chairman & Managing Director Gomathi R, focusing on multispecialty healthcare services from its registered office in Chennai.
Historical Stock Returns for Dharani Finance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.11% | +4.00% | -21.80% | -9.57% | -18.18% | +71.43% |



























